Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

Gene expression and transcription factor profiling reveal inhibition of transcription factor cAMP-response element-binding protein by gamma-herpesvirus replication and transcription activator.

Brown HJ, Peng L, Harada JN, Walker JR, Cole S, Lin SF, Zack JA, Chanda SK, Sun R.

J Biol Chem. 2010 Aug 13;285(33):25139-53. doi: 10.1074/jbc.M110.137737. Epub 2010 Jun 1.

2.

B cell terminal differentiation factor XBP-1 induces reactivation of Kaposi's sarcoma-associated herpesvirus.

Yu F, Feng J, Harada JN, Chanda SK, Kenney SC, Sun R.

FEBS Lett. 2007 Jul 24;581(18):3485-8. Epub 2007 Jun 29.

3.

Systematic identification of cellular signals reactivating Kaposi sarcoma-associated herpesvirus.

Yu F, Harada JN, Brown HJ, Deng H, Song MJ, Wu TT, Kato-Stankiewicz J, Nelson CG, Vieira J, Tamanoi F, Chanda SK, Sun R.

PLoS Pathog. 2007 Mar;3(3):e44.

4.

Identification of novel mammalian growth regulatory factors by genome-scale quantitative image analysis.

Harada JN, Bower KE, Orth AP, Callaway S, Nelson CG, Laris C, Hogenesch JB, Vogt PK, Chanda SK.

Genome Res. 2005 Aug;15(8):1136-44. Epub 2005 Jul 15.

5.

PDX1, a cellular homeoprotein, binds to and regulates the activity of human cytomegalovirus immediate early promoter.

Chao SH, Harada JN, Hyndman F, Gao X, Nelson CG, Chanda SK, Caldwell JS.

J Biol Chem. 2004 Apr 16;279(16):16111-20. Epub 2004 Feb 5.

6.

Analysis of the adenovirus E1B-55K-anchored proteome reveals its link to ubiquitination machinery.

Harada JN, Shevchenko A, Shevchenko A, Pallas DC, Berk AJ.

J Virol. 2002 Sep;76(18):9194-206.

7.
8.

Tumor necrosis factor receptor associated factor 2 is a mediator of NF-kappa B activation by latent infection membrane protein 1, the Epstein-Barr virus transforming protein.

Kaye KM, Devergne O, Harada JN, Izumi KM, Yalamanchili R, Kieff E, Mosialos G.

Proc Natl Acad Sci U S A. 1996 Oct 1;93(20):11085-90.

Supplemental Content

Loading ...
Support Center